Middle East and Africa Pharmaceutical Stability and Storage Services Market Size, Share & Trends Analysis Report By Service Type (Stability, Storage), By Molecule Type (Small Molecule, Large Molecule) and By Country (UAE, Turkey, Saudi Arabia, South Africa, Egypt, Nigeria, Rest of MEA) Forecasts, 2026-2034

Last Updated: September 21, 2026 | Author: Dhanashri Chandgude | Format:

Middle East and Africa Pharmaceutical Stability and Storage Services Market Size

The Middle East and Africa Pharmaceutical Stability and Storage Services Market size was valued at USD 60.0 million in 2025 and is projected to grow from USD 64.49 million in 2026 to reach USD 114.84 million by 2034, growing at a CAGR of 7.48% during the forecast period 2026–2034.

The pharmaceutical stability and storage services market has experienced substantial growth recently, driven by the expanding pharmaceutical industry's demand for reliable and efficient storage solutions. These services involve specialized facilities and expertise to maintain optimal conditions for pharmaceutical products, ensuring their quality and efficacy.

Market Key Takeaways

Global Market Size & Growth

Storage dominated the market by services.

Large molecules dominate the market by molecules.

Outsourcing dominates the market by modes.

Saudi Arabia dominates the market by region.

Middle East and Africa Pharmaceutical Stability and Storage Services Market Size

Download a Free Sample To learn more about this report.

Services Insights

Storage dominated the market and is expected to register a CAGR of 8.0% over the forecast period.

Middle East and Africa Pharmaceutical Stability and Storage Services Market Size By Segments

Request Customizationto receive a tailored report.

Molecules Insights

The Large molecules dominate the market and are expected to register a CAGR of 7.9% over the forecast period.

Modes Insights

The outsourcing market is expected to register a CAGR of 8.4% over the forecast period.

Middle East and Africa Pharmaceutical Stability and Storage Services Market Share By Segments

Speak to an Analystto discuss market opportunities.

Regional Insights

The pharmaceutical stability and storage services market in the Middle East and Africa (Middle East and Africa) region is an emerging sector within the pharmaceutical industry. Countries like Saudi Arabia, United Arab Emirates, South Africa, Egypt, and Nigeria, among others, contribute significantly to this market. Factors driving its growth include the expanding pharmaceutical industry, increasing investments in healthcare, and a growing population. The demand for reliable stability testing and storage services is increasing to ensure the quality, effectiveness, and adherence to regulatory standards of pharmaceutical products. Compliance with regulations set by local authorities, such as the Saudi FDA, UAE Ministry of Health, and SAHPRA, is crucial. Service providers in the Middle East and Africa region play a vital role in supporting pharmaceutical companies in meeting these regulatory requirements by leveraging their expertise and complying with local regulations.

List of Key and Emerging Players in Middle East and Africa Pharmaceutical Stability and Storage Services Market

Catalent Inc.

BioLife Solutions

Almac Group

Roylance Stability Storage Limited

Charles River Laboratories International, Inc.

Alcami Corporation

Lucideon Limited

Q Laboratories

Key Industry Developments

March 2026

DHL Group expanded temperature-controlled pharmaceutical logistics operations across the Middle East by strengthening alternative cold-chain transportation corridors and storage capabilities to ensure continuity of temperature-sensitive medicine distribution during regional supply chain disruptions.

January 2026

Akums Drugs and Pharmaceuticals received European Union Good Manufacturing Practice (EU GMP) certification for two manufacturing facilities, strengthening its pharmaceutical manufacturing and stability-compliant storage capabilities for regulated export markets.

December 2025

Akums Drugs and Pharmaceuticals signed a memorandum of understanding with Sharda University to collaborate on pharmaceutical research, technology transfer, and skill development, supporting innovation relevant to regulated pharmaceutical manufacturing and quality systems.

August 2025

Akums Drugs and Pharmaceuticals partnered with the Government of Zambia to establish a pharmaceutical manufacturing facility, expanding pharmaceutical production and supporting regional storage and quality infrastructure in Africa.

Report Scope

Segmentation

By Service Type 2

Stability
Storage

By Molecule Type 2

Small Molecule
Large Molecule

Competitive Coverage Catalent Inc. · BioLife Solutions · Almac Group · Roylance Stability Storage Limited · Charles River Laboratories International, Inc.

Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Report to Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

The Middle East and Africa pharmaceutical stability and storage services market size is projected to grow from USD 64.49 million in 2026 to USD 114.84 million by 2034, at a CAGR of 7.48% during the forecast period 2026-2034.

Storage is the leading segment for the market during forecast period.

Rising demand for vaccines, increasing demand for biosimilarsare the key drivers for the growth of the Middle East and Africa pharmaceutical stability and storage services market.

The key players in the Middle East and Africa pharmaceutical stability and storage services market include Advantech Co. Ltd, Slabb Inc., Electronics Co. Ltd, NCR Corporation, Source Technologies, Embross Ltd, Meridian Kiosks LLC, RedyRef Interactive Kiosks, Shenzhen Zhengton, Zivelo.

About the Author

Dhanashri Chandgude

Senior Research Associate

Dhanashri Chandgude is a healthcare research professional with over four years of experience in market intelligence, specializing in market analysis, secondary research, market estimation, and forecasting across the pharmaceutical, biopharmaceutical, and medical device sectors. She provides actionable insights into market dynamics, competitive intelligence, industry trends, and growth opportunities to support strategic business decision-making.

Her expertise includes assessing market size, growth potential, and revenue opportunities through structured market estimation and forecasting methodologies, including top-down, bottom-up, and epidemiology (EPI)-based approaches. She has hands-on experience analyzing disease epidemiology, treatment landscapes, market trends, competitive scenarios, and industry developments to develop robust market forecasts.